Emicizumab-Kxwh (Subcutaneous Route)

Name: Emicizumab-Kxwh (Subcutaneous Route)

US Brand Name

  1. Hemlibra

Descriptions

Emicizumab-kxwh injection is used to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A (congenital Factor VIII deficiency).

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Solution

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of emicizumab-kxwh injection in children. Safety and efficacy have been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of emicizumab-kxwh injection in the elderly.

Other Interactions

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

  • Bleeding problem or
  • Blood vessel problem—Use with caution. May make these conditions worse.
(web3)